MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy
Open Access
- 18 September 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (9) , 713
Abstract
Becker muscular dystrophy (BMD) is an X-linked recessive disorder caused by dystrophin gene mutations. The phenotype and evolution of this muscle disorder are extremely clinical variable. In the last years, circulating biomarkers have acquired remarkable importance in their use as noninvasive biological indicators of prognosis and in monitoring muscle disease progression, especially when associated to muscle MRI imaging. We investigated the levels of circulating microRNAs (myo-miRNAs and inflammatory miRNAs) and of the proteins follistatin (FSTN) and myostatin (GDF-8) and compared results with clinical and radiological imaging data. In eight BMD patients, including two cases with evolving lower extremity weakness treated with deflazacort, we evaluated the expression level of 4 myo-miRNAs (miR-1, miR-206, miR-133a, and miR-133b), 3 inflammatory miRNAs (miR-146b, miR-155, and miR-221), FSTN, and GDF-8 proteins. In the two treated cases, there was pronounced posterior thigh and leg fibrofatty replacement assessed by muscle MRI by Mercuri score. The muscle-specific miR-206 was increased in all patients, and inflammatory miR-221 and miR-146b were variably elevated. A significant difference in myostatin expression was observed between steroid-treated and untreated patients. This study suggests that microRNAs and myostatin protein levels could be used to better understand the progression and management of the disease.Keywords
This publication has 49 references indexed in Scilit:
- Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular DystrophyPLOS ONE, 2013
- Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for TherapyMolecular Therapy Nucleic Acids, 2012
- miRNAs as serum biomarkers for Duchenne muscular dystrophyEMBO Molecular Medicine, 2011
- Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancersMedicinal Research Reviews, 2010
- Distinctive patterns of microRNA expression in primary muscular disordersProceedings of the National Academy of Sciences, 2007
- Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling PathwaysPLOS ONE, 2007
- A short protocol for muscle MRI in children with muscular dystrophiesEuropean Journal of Paediatric Neurology, 2002
- A short protocol for muscle MRI in children with muscular dystrophiesEuropean Journal of Paediatric Neurology, 2002
- Regulation of skeletal muscle mass in mice by a new TGF-p superfamily memberNature, 1997
- An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locusGenomics, 1988